AbstractPulmonary complications are important cause of mortality and morbidity after hematopoietic stem cell transplantation, in 30% to 60% of the patients. Improvements in prophylaxis and treatment of infectious complications have been increasing the rate of non-infectious complications. Early diagnosis and treatment of those complications can significantly change the evolution of hematopoietic stem cell transplantation receptors.The objective of this study is to review the most frequent non-infection complications associated to hematopoietic stem cell transplantation since the first bone marrow transplantation performed in 1957.A systematic literature review was performed, using the PICO strategy to ask the questions. The descriptors hema...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
Transplante de medula óssea (TMO) é um procedimento terapêutico que tem como o objetivo a substituiç...
WOS: 000288784700022PubMed ID: 21403586Background. Late-onset noninfectious pulmonary complications ...
As complicações pulmonares constituem importante causa de morbidade e mortalidade após o transplante...
Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignan...
Resumo: As complicações pulmonares constituem importante causa de morbidade e mortalidade após o tra...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently more preva...
Pediatric data about early or long-term pulmonary complications of hematopoietic stem cell transplan...
AbstractPulmonary dysfunction is a significant complication following allogeneic hematopoietic stem ...
Donor lymphocyte infusion (DLI) is a therapeutic modality for relapsed hematological malignancies af...
Of 50,000 to 60,000 hematopoietic stem cell trans-plants (HSCTs) performed annually, 35,000 to 40,00...
none7nono abstract availablenoneMasetti R;Zama D;Vendemini F;Prete A;Gentili A;Lima M;Pession AMaset...
AbstractPulmonary complications are a significant cause of early mortality (before day 100) after bo...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
Transplante de medula óssea (TMO) é um procedimento terapêutico que tem como o objetivo a substituiç...
WOS: 000288784700022PubMed ID: 21403586Background. Late-onset noninfectious pulmonary complications ...
As complicações pulmonares constituem importante causa de morbidade e mortalidade após o transplante...
Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignan...
Resumo: As complicações pulmonares constituem importante causa de morbidade e mortalidade após o tra...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently more preva...
Pediatric data about early or long-term pulmonary complications of hematopoietic stem cell transplan...
AbstractPulmonary dysfunction is a significant complication following allogeneic hematopoietic stem ...
Donor lymphocyte infusion (DLI) is a therapeutic modality for relapsed hematological malignancies af...
Of 50,000 to 60,000 hematopoietic stem cell trans-plants (HSCTs) performed annually, 35,000 to 40,00...
none7nono abstract availablenoneMasetti R;Zama D;Vendemini F;Prete A;Gentili A;Lima M;Pession AMaset...
AbstractPulmonary complications are a significant cause of early mortality (before day 100) after bo...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
Transplante de medula óssea (TMO) é um procedimento terapêutico que tem como o objetivo a substituiç...
WOS: 000288784700022PubMed ID: 21403586Background. Late-onset noninfectious pulmonary complications ...